NCT00467987

Effect of Androgel on Atherogenesis in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism

Effect of Androgel on Atherogenesis, Inflammation, Cardiovascular Risk Factors And Adiposity in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism.: a Prospective, Randomized and Controlled-Study

• Status: Terminated
• Phase: N/A
• Study type: Interventional
• Enrollment: 47 (actual)
• Sponsor: University at Buffalo · Academic / Other
• Sex: Male
• Age: 31 Years – 60 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to examine the effects of testosterone deficiency in men with diabetes on atherogenesis, inflammation, cardiovascular Risk factors And adiposity .

Detailed description

The purpose of this study is to examine the effects of testosterone deficiency in men with diabetes on atherogenesis, inflammation, cardiovascular Risk factors And adiposity . This will be done by comparing the changes in several body response indicators following treatment with testosterone in diabetic men with low testosterone levels and comparing them to diabetic men with low testosterone who are not treated with testosterone. These groups will also be compared with diabetic men who have normal testosterone levels

Conditions

• Type 2 Diabetic Male With Hypogonadotrophic Hypogonadism

Interventions

Type	Name	Description
DRUG	androgel	androgel 1%
DRUG	placebo	placebo

Timeline

• Start date: 2007-06-01
• Primary completion: 2018-03-01
• Completion: 2018-10-11
• First posted: 2007-05-01
• Last updated: 2024-02-06
• Results posted: 2024-02-06

Locations

1 site across 1 country: United States